Spyre Therapeutics Announces Grants of Inducement Awards

WALTHAM, Mass., June 3, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. , a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations,...

Related Keywords

,Linkedin ,Prnewswire Spyre Therapeutics Inc ,Nasdaq ,Compensation Committee Of The Board Directors ,Company Or Spyre ,Spyre Therapeutics Inc ,Inflammatory Bowel Disease ,Compensation Committee ,Spyre Therapeutics ,Inducement Plan ,Nasdaq Listing Rule ,